174 related articles for article (PubMed ID: 33080414)
1. Expression and prognostic roles of PABPC1 in hepatocellular carcinoma.
YuFeng Z; Ming Q
Int J Surg; 2020 Dec; 84():3-12. PubMed ID: 33080414
[TBL] [Abstract][Full Text] [Related]
2. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
3. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
[TBL] [Abstract][Full Text] [Related]
4. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
5. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
[TBL] [Abstract][Full Text] [Related]
8. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis.
Chi Q; Geng X; Xu K; Wang C; Zhao H
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629
[TBL] [Abstract][Full Text] [Related]
9. SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
Chen Y; Zhao J; Jiao Z; Wang W; Wang D; Yu X; Shi Z; Ge N; Pan Q; Xia J; Niu W; Zhao R; Zhang X; Du W
BMC Cancer; 2018 Dec; 18(1):1240. PubMed ID: 30537941
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
[TBL] [Abstract][Full Text] [Related]
11. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma.
Zhang H; Sheng C; Yin Y; Wen S; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2015 Oct; 367(1):49-57. PubMed ID: 26188282
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
Xu W; Rao Q; An Y; Li M; Zhang Z
PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
14. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network.
Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W
DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Genes in Hepatocellular Carcinoma Related to Progression and Prognosis by Weighted Gene Co-Expression Network Analysis.
Li J; Wang X; Yang J; Zhao S; Liu T; Wang L
Med Sci Monit; 2020 Mar; 26():e920854. PubMed ID: 32200387
[TBL] [Abstract][Full Text] [Related]
16. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
18. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
19. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
20. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
